Sanara Medtech Stock

Sanara Medtech FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Sanara Medtech (SMTI) as of Aug 15, 2026 is -5.75 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 2.62 % — a change of -319.69% (lower).

FCF Conversion

-5.75 %

YoY

-319.69%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Sanara Medtech is 2026 -5.75 % . FCF Conversion Rate (FCF/EBITDA) of Sanara Medtech was 2025 2.62 % . It decreases by -319.69% lower compared to the previous year.
Access this data via the Eulerpool API

Sanara Medtech Stock analysis

What does Sanara Medtech do? Sanara Medtech Inc is a leading company specializing in the development of innovative medical devices and solutions. The company is headquartered in Texas, USA and has experienced significant growth since its founding in 2014. Its areas of specialization include wound care, incontinence management, and dermatology. The history of Sanara Medtech Inc began in 2014 when a team of experienced medical technology experts founded the company. Leveraging their extensive industry knowledge and expertise, the team quickly identified a market niche and established themselves as a leading provider of innovative solutions. The business model of Sanara Medtech Inc is focused on developing medical devices and solutions that aim to improve the daily lives of patients and healthcare professionals. The company is committed to developing and manufacturing top-quality products that contribute to enhancing patient care and supporting healthcare professionals in their tasks. Sanara Medtech Inc offers a wide range of products tailored to the needs of patients and medical professionals. Its wound care products include wound dressings, wound healing ointments, and other specialized products for treating chronic and acute wounds. The incontinence management products include disposable and reusable incontinence products designed to improve the lives of individuals with incontinence issues. Dermatology products encompass a wide range of products for treating skin conditions such as psoriasis, eczema, and rosacea, to name a few. Another focus of Sanara Medtech Inc is collaborating with private and public healthcare facilities to ensure the availability of its products in hospitals, clinics, nursing homes, and other healthcare facilities. The company also offers training and educational programs for healthcare professionals to ensure proper product use. In summary, Sanara Medtech Inc is an innovative company specializing in the development of medical devices and solutions tailored to the needs of patients and healthcare professionals. Its goal is to develop top-quality products that contribute to the improvement of healthcare and enhance the lives of patients. With a wide range of products and a strong market presence, Sanara Medtech Inc is a leading force in the medical technology industry. Sanara Medtech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanara Medtech stock

FCF Conversion Rate (FCF/EBITDA) of Sanara Medtech is -5.75 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Sanara Medtech changed from 2.62 % to -5.75 %, representing a -319.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Sanara Medtech since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Sanara Medtech with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Sanara Medtech

All Key Metrics — Sanara Medtech